未登录

L

Lifeng Yu

China Medical University

H指数:16

被引数:971

浏览量:0

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Antibody-Drug Conjugates (ADCs): current and future biopharmaceuticals

抗体-药物结合物 (adc): 当前和未来的生物制药

JOURNAL OF HEMATOLOGY & ONCOLOGY

IF40.4

2025-04-300

OA

When will the immune-stimulating antibody conjugates (ISACs) be transferred from bench to bedside?

PHARMACOLOGICAL RESEARCH

IF10.5

2024-05-014

OAAI

Peptide-drug conjugates (PDCs): a novel trend of research and development on targeted therapy, hype or hope?

ACTA PHARMACEUTICA SINICA B

IF14.6

2023-02-0188

OAAI

Advances of research of Fc-fusion protein that activate NK cells for tumor immunotherapy

INTERNATIONAL IMMUNOPHARMACOLOGY

IF4.7

2022-08-0110

PRE

Computational Recognition of a Regulatory T-cell-specific Signature With Potential Implications in Prognosis, Immunotherapy, and Therapeutic Resistance of Prostate Cancer

FRONTIERS IN IMMUNOLOGY

IF5.9

2022-06-236

OAAI

MiR-302a/b/c/d cooperatively sensitizes breast cancer cells to adriamycin via suppressing P- glycoprotein(P-gp) by targeting MAP/ERK kinase kinase 1 (MEKK1) (vol 35, 25, 2016)

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

IF12.8

2022-03-120

OAAI

Intrinsic adriamycin resistance in p53-mutated breast cancer is related to the miR-30c/FANCF/REV1-mediated DNA damage response (vol 10, 666, 2019)

CELL DEATH & DISEASE

IF9.6

2022-01-251

OAAI

Basal Ganglia Calcification Is Associated With Local and Systemic Metabolic Mechanisms in Adult Hypoparathyroidism

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

IF5.1

2021-03-3111

OA

BRAF and KRAS mutations in metastatic colorectal cancer: future perspectives for personalized therapy

GASTROENTEROLOGY REPORT

IF4.2

2020-06-1579

OAAI

The LQT-associated calmodulin mutant E141G induces disturbed Ca2+-dependent binding and a flickering gating mode of the CaV1.2 channel

与LQT相关的钙调蛋白突变体E141G诱导Ca2依赖性结合受到干扰，并且CaV1.2通道的闪烁门控模式

AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY

IF4.7

2020-05-0110

PREAI

Intrinsic adriamycin resistance in p53-mutated breast cancer is related to the miR-30c/FANCF/REV1-mediated DNA damage response

CELL DEATH & DISEASE

IF9.6

2019-09-1124

OAAI

MiR-302a/b/c/d cooperatively sensitizes breast cancer cells to adriamycin via suppressing P-glycoprotein(P-gp) by targeting MAP/ERK kinase kinase 1 (MEKK1)

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

IF12.8

2016-02-0376

OAAI

PKA and phosphatases attached to the CaV1.2 channel regulate channel activity in cell-free patches

附着在CaV1.2通道上的PKA和磷酸酶调节无细胞斑块中的通道活性

AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY

IF4.7

2016-01-1510

PREAI

RETRACTED: miR-181a Induces Macrophage Polarized to M2 Phenotype and Promotes M2 Macrophage-mediated Tumor Cell Metastasis by Targeting KLF6 and C/EBPα (Retracted article. See vol. 28, pg. 792, 2022)

MOLECULAR THERAPY-NUCLEIC ACIDS

IF0

2016-01-0162

OAAI

Electrophysiological effect and the gating mechanism of astragaloside IV on L-type Ca2+ channels of guinea-pig ventricular myocytes

黄芪甲苷对豚鼠心室肌细胞L型Ca2通道的电生理作用及其门控机制

EUROPEAN JOURNAL OF PHARMACOLOGY

IF4.7

2015-08-0110

PREAI

Adenosine triphosphate regulates the activity of guinea pig Cav1.2 channel by direct binding to the channel in a dose-dependent manner

AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY

IF4.7

2014-05-0116

PREAI